(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
4 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 6.61%
0.47% $ 80.97
@ $80.96
Выпущен: 25 апр. 2024 @ 22:38
Доходность: 0.01%
Предыдущий сигнал: апр. 25 - 19:49
Предыдущий сигнал:
Доходность: 0.63 %
Live Chart Being Loaded With Signals
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally...
Stats | |
---|---|
Объем за сегодня | 435 170 |
Средний объем | 831 755 |
Рыночная капитализация | 11.15B |
EPS | $0 ( 2024-02-13 ) |
Дата следующего отчета о доходах | ( $0.460 ) 2024-05-02 |
Last Dividend | $0.0500 ( 2024-02-29 ) |
Next Dividend | $0 ( N/A ) |
P/E | 27.92 |
ATR14 | $1.870 (2.31%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-16 | Laukien Frank H | Sell | 1 404 | Common Stock |
2024-03-04 | Requardt Hermann Fritz | Buy | 10 000 | Common Stock |
2024-03-04 | Requardt Hermann Fritz | Buy | 5 000 | Common Stock |
2024-03-04 | Requardt Hermann Fritz | Sell | 13 772 | Common Stock |
2024-03-04 | Requardt Hermann Fritz | Sell | 1 228 | Common Stock |
INSIDER POWER |
---|
-31.67 |
Last 100 transactions |
Buy: 483 678 | Sell: 1 126 200 |
Объем Корреляция
Bruker Corp Корреляция
10 Самые положительные корреляции | |
---|---|
SVFA | 0.921 |
SKYA | 0.916 |
AEAC | 0.915 |
PPTA | 0.914 |
ARRW | 0.913 |
AMTBB | 0.912 |
LFAC | 0.911 |
INTE | 0.911 |
ESCA | 0.91 |
HORI | 0.91 |
10 Самые отрицательные корреляции | |
---|---|
BMRA | -0.919 |
BWB | -0.911 |
HRMY | -0.91 |
SLN | -0.906 |
INCR | -0.903 |
SFST | -0.903 |
EQBK | -0.902 |
PEAR | -0.902 |
PMVP | -0.902 |
CSSEP | -0.901 |
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Bruker Corp Корреляция - Валюта/Сырье
Bruker Corp Финансовые показатели
Annual | 2023 |
Выручка: | $2.96B |
Валовая прибыль: | $1.52B (51.17 %) |
EPS: | $2.92 |
FY | 2023 |
Выручка: | $2.96B |
Валовая прибыль: | $1.52B (51.17 %) |
EPS: | $2.92 |
FY | 2022 |
Выручка: | $2.53B |
Валовая прибыль: | $1.31B (51.59 %) |
EPS: | $2.00 |
FY | 2022 |
Выручка: | $2.53B |
Валовая прибыль: | $1.31B (51.59 %) |
EPS: | $2.00 |
Financial Reports:
No articles found.
Bruker Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0400 | 2016-03-02 |
Last Dividend | $0.0500 | 2024-02-29 |
Next Dividend | $0 | N/A |
Payout Date | 2024-03-15 | |
Next Payout Date | N/A | |
# dividends | 33 | -- |
Total Paid Out | $1.410 | -- |
Avg. Dividend % Per Year | 0.21% | -- |
Score | 4.59 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.12 | |
Div. Directional Score | 8.92 | -- |
Year | Amount | Yield |
---|---|---|
2016 | $0.160 | 0.68% |
2017 | $0.160 | 0.74% |
2018 | $0.160 | 0.46% |
2019 | $0.160 | 0.55% |
2020 | $0.160 | 0.31% |
2021 | $0.160 | 0.30% |
2022 | $0.200 | 0.25% |
2023 | $0.200 | 0.29% |
2024 | $0.0500 | 0.07% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.144 | 1.500 | 7.12 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.101 | 1.200 | 6.65 | 7.98 | [0 - 0.3] |
returnOnEquityTTM | 0.338 | 1.500 | 7.35 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.0688 | -1.000 | 9.31 | -9.31 | [0 - 1] |
currentRatioTTM | 1.800 | 0.800 | 6.00 | 4.80 | [1 - 3] |
quickRatioTTM | 0.933 | 0.800 | 9.22 | 7.37 | [0.8 - 2.5] |
cashRatioTTM | 0.406 | 1.500 | 8.85 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.303 | -1.500 | 4.94 | -7.42 | [0 - 0.6] |
interestCoverageTTM | -11.98 | 1.000 | -5.55 | -5.55 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.41 | 2.00 | 9.20 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.671 | 2.00 | 9.16 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.936 | -1.500 | 6.26 | -9.38 | [0 - 2.5] |
grossProfitMarginTTM | 0.510 | 1.000 | 4.84 | 4.84 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.149 | 1.000 | 9.02 | 9.02 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.272 | 1.000 | 9.60 | 9.60 | [0.2 - 2] |
assetTurnoverTTM | 0.698 | 0.800 | 8.68 | 6.95 | [0.5 - 2] |
Total Score | 11.71 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 27.58 | 1.000 | 7.32 | 0 | [1 - 100] |
returnOnEquityTTM | 0.338 | 2.50 | 8.30 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.671 | 2.00 | 9.44 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.247 | 1.500 | 3.82 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.41 | 2.00 | 9.20 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0688 | 1.500 | 9.31 | -9.31 | [0 - 1] |
pegRatioTTM | 0.361 | 1.500 | -0.929 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.118 | 1.000 | 9.55 | 0 | [0.1 - 0.5] |
Total Score | 6.12 |
Bruker Corp
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа